Sydney, Feb 15, 2006 AEST (ABN Newswire) - Leading cell therapy services company CyGenics Ltd. (ASX: CYN) today announced the appointment of Mr Alberto J. Bautista to its Board of Directors, as a non-executive director.
Mr Bautista is an industry veteran of many years' standing, and was appointed Senior Consultant, Global Alliances & Corporate Development for CyGenics, in January 2005. Utilising his industry background, extensive contacts and expertise, he provided strategic advice and support to CyGenics for its global expansion. He also facilitated high level discussions on potential mergers and acquisitions, and provided guidance in the organisational structure and staffing of the group.
Prior to this appointment, Mr Bautista was with Baxter International for nearly 30 years. Baxter assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, haemophilia, immune disorders, kidney disease, and trauma worldwide. The NYSE-listed company had sales in 2005 of US$9.8 billion. Mr Bautista has worked for Baxter in several countries on four continents, most recently as a Vice President with its Japan office, where he was responsible for US$300 million in sales. From 1997 to 2001, he was President of Baxter Healthcare Asia. From 1992 to 1997, he was responsible for four Baxter businesses in this region, tripling the company's sales in those five years. Mr Bautista graduated with a Bachelors in Industrial Engineering from the University of the Philippines, and holds a Masters in Management from the Sloan School of the Massachusetts Institute of Technology.
"Al has made a valuable contribution over the past year," said Chris Fullerton, Chairman, CyGenics. "I heartily welcome him to the board, where his expertise, experience and broad industry contacts will enhance the level of support and guidance which directors can offer our management team, and will add depth to the board's corporate governance role."
Contact
Steven Fang, CEO, CyGenics Ltd
Mob: +61 (0)400 933 243
Email: steven.fang@cygenics.com
Ian Brown, COO, CyGenics Ltd
Mob: +61 (0)438 565 212
Email: ian.brown@cygenics.com
Media Inquiries
Rebecca Piercy, Buchan Consulting
Ph: +61 (0)3 9866 4722
Mob: +61 (0)422 916 422
Email: rpiercy@bcg.com.au
Ronald Hee, CyGenics Ltd
Ph: +65 6238 0808
Mob: +65 9061 9098
Email: ronald.hee@cygenics.com
| ||
|
